LYNX1 CAPITAL MANAGEMENT LP
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GHRS | 10.76M | $151.33M |
 | CGEM | 8.96M | $127.37M |
 | TCRX | 8.02M | $8.10M |
 | CCCC | 7.00M | $18.41M |
 | STOK | 4.76M | $155.11M |
 | AGIO | 2.61M | $88.35M |
 | DNLI | 1.88M | $36.10M |
 | VYNE | 1.63M | $973.15K |
 | KRRO | 1.54M | $17.41M |
 | DTIL | 985K | $5.42M |
 | NEUP | 875K | $3.56M |
 | HOWL | 658K | $547.67K |
 | PASG | 624K | $4.90M |
 | XNCR | 536K | $6.47M |
 | IMTX | 217K | $2.14M |
 | TRDA | 212K | $2.67M |
 | DSGN | 120K | $1.27M |
 | PRQR | 68K | $110.95K |
 | IBIO | 68K | $129.34K |
 | CGON | 32K | $2.14M |
GH Research PLC
GHRS
Shares Held
10.76M
Value
$151.33M
Cullinan Therapeutics, Inc.
CGEM
Shares Held
8.96M
Value
$127.37M
TScan Therapeutics, Inc.
TCRX
Shares Held
8.02M
Value
$8.10M
C4 Therapeutics, Inc.
CCCC
Shares Held
7.00M
Value
$18.41M
Stoke Therapeutics, Inc.
STOK
Shares Held
4.76M
Value
$155.11M
Agios Pharmaceuticals, Inc.
AGIO
Shares Held
2.61M
Value
$88.35M
Denali Therapeutics Inc.
DNLI
Shares Held
1.88M
Value
$36.10M
VYNE Therapeutics Inc.
VYNE
Shares Held
1.63M
Value
$973.15K
Korro Bio, Inc.
KRRO
Shares Held
1.54M
Value
$17.41M
Precision BioSciences, Inc.
DTIL
Shares Held
985K
Value
$5.42M
Neuphoria Therapeutics Inc.
NEUP
Shares Held
875K
Value
$3.56M
Werewolf Therapeutics, Inc.
HOWL
Shares Held
658K
Value
$547.67K
Passage Bio, Inc.
PASG
Shares Held
624K
Value
$4.90M
Xencor, Inc.
XNCR
Shares Held
536K
Value
$6.47M
Immatics N.V.
IMTX
Shares Held
217K
Value
$2.14M
Entrada Therapeutics, Inc.
TRDA
Shares Held
212K
Value
$2.67M
Design Therapeutics, Inc.
DSGN
Shares Held
120K
Value
$1.27M
ProQR Therapeutics N.V.
PRQR
Shares Held
68K
Value
$110.95K
iBio, Inc.
IBIO
Shares Held
68K
Value
$129.34K
CG Oncology, Inc. Common stock
CGON
Shares Held
32K
Value
$2.14M